First Time Loading...

BRAIN Biotech AG
XETRA:BNN

Watchlist Manager
BRAIN Biotech AG Logo
BRAIN Biotech AG
XETRA:BNN
Watchlist
Price: 2.78 EUR -1.07% Market Closed
Updated: Apr 24, 2024

Operating Margin
BRAIN Biotech AG

-10.4%
Current
-15%
Average
6.3%
Industry
Negative for the last year
-10.4%
Negative average
-15%
Better than average
Worse than industry value

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-10.4%
=
Operating Profit
-5.7m
/
Revenue
55.2m

Operating Margin Across Competitors

Operating Margin Comparison
BRAIN Biotech AG Competitors

Country Company Market Cap Operating
Margin
DE
BRAIN Biotech AG
XETRA:BNN
60.7m EUR
-10%
JP
Shin-Etsu Chemical Co Ltd
TSE:4063
12.4T JPY
30%
US
Sherwin-Williams Co
NYSE:SHW
77.1B USD
16%
US
Ecolab Inc
NYSE:ECL
62.9B USD
14%
CH
Sika AG
SIX:SIKA
41.5B CHF
15%
CH
Givaudan SA
SIX:GIVN
36.6B CHF
16%
CN
Wanhua Chemical Group Co Ltd
SSE:600309
265.3B CNY
12%
IN
Asian Paints Ltd
NSE:ASIANPAINT
2.8T INR
19%
US
Dupont De Nemours Inc
NYSE:DD
31.7B USD
14%
US
PPG Industries Inc
NYSE:PPG
30.7B USD
12%
CH
DSM-Firmenich AG
AEX:DSFIR
28.2B EUR
-4%
BRAIN Biotech AG
XETRA:BNN
Country DE
Market Cap 60.7m EUR
Operating Margin
-10%
Shin-Etsu Chemical Co Ltd
TSE:4063
Country JP
Market Cap 12.4T JPY
Operating Margin
30%
Sherwin-Williams Co
NYSE:SHW
Country US
Market Cap 77.1B USD
Operating Margin
16%
Ecolab Inc
NYSE:ECL
Country US
Market Cap 62.9B USD
Operating Margin
14%
Sika AG
SIX:SIKA
Country CH
Market Cap 41.5B CHF
Operating Margin
15%
Givaudan SA
SIX:GIVN
Country CH
Market Cap 36.6B CHF
Operating Margin
16%
Wanhua Chemical Group Co Ltd
SSE:600309
Country CN
Market Cap 265.3B CNY
Operating Margin
12%
Asian Paints Ltd
NSE:ASIANPAINT
Country IN
Market Cap 2.8T INR
Operating Margin
19%
Dupont De Nemours Inc
NYSE:DD
Country US
Market Cap 31.7B USD
Operating Margin
14%
PPG Industries Inc
NYSE:PPG
Country US
Market Cap 30.7B USD
Operating Margin
12%
D
DSM-Firmenich AG
AEX:DSFIR
Country CH
Market Cap 28.2B EUR
Operating Margin
-4%

Profitability Report

View the profitability report to see the full profitability analysis for BRAIN Biotech AG.

Full Profitability Report

See Also

Summary
BNN intrinsic value, competitors valuation, and company profile.
DCF Valuation
BNN stock valuation using Discount Cash Flow valuation method.
Relative Valuation
BNN stock valuation using valuation multiples.
Wall Street Estimates
BNN price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
BNN stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-10.4%
=
Operating Profit
-5.7m
/
Revenue
55.2m
What is the Operating Margin of BRAIN Biotech AG?

Based on BRAIN Biotech AG's most recent financial statements, the company has Operating Margin of -10.4%.

ALPHA SPREAD
Join more than 130,700+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.